139 related articles for article (PubMed ID: 1021403)
1. [Changes of the exocrine pancreatic function and results of secretin therapy in duodenal ulcer].
Brailski VC; Mendisova A; Dimitrov B
Dtsch Z Verdau Stoffwechselkr; 1976; 36(3-4):245-7. PubMed ID: 1021403
[No Abstract] [Full Text] [Related]
2. Proceedings: A comparison of basal and stimulated gastric and pancreatic secretion in patients with and without duodenal ulcer disease.
Gutierrez LV; Baron JH
Gut; 1974 Oct; 15(10):836. PubMed ID: 4434957
[No Abstract] [Full Text] [Related]
3. The pancreatic exocrine secretion in duodenal ulcer patients before and after selective proximal vagotomy of the stomach.
Berstad A; Roland M; Petersen H; Liaväg I
Scand J Gastroenterol; 1974; 9(5):431-6. PubMed ID: 4854985
[No Abstract] [Full Text] [Related]
4. Secretin snuff: evaluation of the action on pentagastrin-stimulated gastric acid secretion and on pancreatic bicarbonate production.
Halter F; Witzel L; Kohler B; Hadorn B
Scand J Gastroenterol; 1975; 10(1):81-5. PubMed ID: 1168364
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of gastric secretion by exogenous secretin and cholecystokinin in normals and duodenal ulcer patients.
Jörgensen SP; Henriksen FW
Scand J Gastroenterol Suppl; 1976; 37():39-42. PubMed ID: 1064138
[TBL] [Abstract][Full Text] [Related]
6. Treatment of duodenal ulcer with a long-acting synthetic secretin: a pilot trial.
Demling L; Domschke W; Domschke S; Belohlavek D; Baenkler HW; Frühmorgen P; Lingenberg G; Wünsch E; Jaeger E
Acta Hepatogastroenterol (Stuttg); 1975 Oct; 22(5):310-3. PubMed ID: 53980
[TBL] [Abstract][Full Text] [Related]
7. Inhibition by secretin of the gastric acid responses to meals and to pentagastrin in duodenal ulcer patients.
Konturek SJ; Biernat J; Grzelec T
Gut; 1973 Nov; 14(11):842-6. PubMed ID: 4761603
[TBL] [Abstract][Full Text] [Related]
8. [Effect of atropine on stimulation by secretin of the pancreatic secretion in patients with duodenal ulcer].
Geller LI; Glinskaia TP; Kozlova ZP
Ter Arkh; 1976; 48(12):83-7. PubMed ID: 1013901
[No Abstract] [Full Text] [Related]
9. Proceedings: Secretin release in man after intra-duodenal acid.
Bloom SR; Ward AS
Gut; 1974 Apr; 15(4):338. PubMed ID: 4834563
[No Abstract] [Full Text] [Related]
10. Response to pentagastrin in man. II. Secretion of acid.
Wormsley KG
Acta Hepatogastroenterol (Stuttg); 1973; 20(2):150-8. PubMed ID: 4751156
[No Abstract] [Full Text] [Related]
11. Relationship between gastric and pancreatic secretion in patients with duodenal ulcer.
Petersen H
Scand J Gastroenterol; 1970; 5(5):321-6. PubMed ID: 5455817
[No Abstract] [Full Text] [Related]
12. [Effect of calcitonin on gastric and pancreatic secretion and on the formation of experimental peptic ulcers in cats (author's transl)].
Radecki T; Konturek SJ; Thor P; Demitrescu T; Pucher A
Przegl Lek; 1974; 31(2):293-8. PubMed ID: 4831810
[No Abstract] [Full Text] [Related]
13. The effect of portacaval shunting on the exocrine pancreatic maximum secretory capacity.
Ashikari H; Dreiling DA
Am J Gastroenterol; 1968 Apr; 49(4):312-7. PubMed ID: 5650744
[No Abstract] [Full Text] [Related]
14. [The etiopathogenesis and therapy of gastric and duodenal ulcer].
Lattanzi A
Clin Ter; 1978 Sep; 86(6):515-35. PubMed ID: 367685
[No Abstract] [Full Text] [Related]
15. Endogenous acid releases secretin in man.
Domschke W; Greenberg GR; Domschke S; Bloom SR; Mitznegg P; Sprügel W; Demling L
Acta Hepatogastroenterol (Stuttg); 1977 Oct; 24(5):262-3. PubMed ID: 930532
[TBL] [Abstract][Full Text] [Related]
16. Newer concepts of pancreatic secretory patterns. Pancreatic secretory mass and pancreatic secretory capacity: pancreatic hypersecretion.
Dreiling DA; Greenstein A; Bordalo O
Mt Sinai J Med; 1973; 40(5):666-76. PubMed ID: 4542420
[No Abstract] [Full Text] [Related]
17. Studies with a new anti-secretory drug (UK 5850) in rats and man.
Hogbin BM; Cox SP; Johnson PA; Bugden RD; Bennett A; Pullman LG; Stevens EA
Br J Surg; 1972 Nov; 59(11):902. PubMed ID: 4637104
[No Abstract] [Full Text] [Related]
18. Gastrointestinal effects of long-term treatment of duodenal ulcer with depot secretin: clinical, secretory, ultra-structural, and enzymological aspects.
Demling L; Domschke W; Riemann JF; Domschke S; Ruppin H; Junge O; Wünsch E
Scand J Gastroenterol Suppl; 1976; 42():136-45. PubMed ID: 796967
[No Abstract] [Full Text] [Related]
19. The effect of a new depot secretin on the gastric and pancreatic secretions in humans.
Demling L; Classen M; Koch H; Domschke W
Acta Hepatogastroenterol (Stuttg); 1973; 20(4):324-30. PubMed ID: 4586496
[No Abstract] [Full Text] [Related]
20. Effect of secretin on gastric function in normal subjects and in patients with duodenal ulcer.
Dalton MD; Eisenstein AM; Walsh JH; Fordtran JS
Gastroenterology; 1976 Jul; 71(1):24-9. PubMed ID: 1278646
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
